Difference between revisions of "COVID Monkey Study"
From iGeek
Line 8: | Line 8: | ||
* https://www.nature.com/articles/s41577-020-0316-3 | * https://www.nature.com/articles/s41577-020-0316-3 | ||
{{/ref| Immunity and COVID mutation rate|COVID Studies}} | {{/ref| Immunity and COVID mutation rate|COVID Studies}} | ||
− | [[Category:COVID-Immunity]][[Category:COVID | + | [[Category:COVID-Immunity]][[Category:COVID Studies]] |
</noinclude> | </noinclude> |
Latest revision as of 22:53, 29 April 2020
2020.04.17 SARS-CoV-2 study on rhesus macaques seems to show at least limited immunity.
❝ In this preprint, Bao et al. investigated acquired immunity to. Four rhesus monkeys were infected with SARS-CoV-2 and two were reinfected after confirmed recovery. After primary infection, viral replication was detected in the nose, pharynx, lungs and gut, with histopathological evidence of lung damage. Sera collected from recovered monkeys before reinfection exhibited neutralizing activity against SARS-CoV-2. Upon reinfection, viral replication was not detected in nasopharyngeal or anal swabs, and reinfected monkeys did not show any signs of COVID-19 disease recurrence. This suggests that immunity acquired following primary infection with SARS-CoV-2 may protect upon subsequent exposure to the virus. ❞
|
| ||||||